Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-EN Version v6-EN
Language English English
Date Updated 2023-02-06 2022-07-29
Drug Identification Number 00839205 00839205
Brand name SANDOSTATIN SANDOSTATIN
Common or Proper name SANDOSTATIN 100UG 1ML 1X5 SANDOSTATIN 100UG 1ML 1X5
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients OCTREOTIDE OCTREOTIDE
Strength(s) 100MCG 100MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS
Packaging size 1mL 1mL
ATC code H01CB H01CB
ATC description HYPOTHALAMIC HORMONES HYPOTHALAMIC HORMONES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2022-05-10 2022-05-10
Actual start date 2022-07-29
Estimated end date 2023-02-13 2022-09-22
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Limited quantity available. On allocation
Health Canada comments